VV

Vidhyalakshmi Venkataramanan

Active Director Director DIN 10301142
DIN 10301142 First appointment Aug 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Vidhyalakshmi Venkataramanan

Data last updated:

Vidhyalakshmi Venkataramanan is a Director at Negan Nutraceuticals Private Limited (since 2023). The company operates in Pharma.

DIN 10301142
Primary Designation Director
Industry Pharma
First Appointment 31 Aug 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Negan Nutraceuticals Private Limited U86909TS2023PTC176640
Director31 Aug 20232023Active

Board colleagues of Vidhyalakshmi Venkataramanan

NameDINCompanyDesignation
Kumaresan Baburajendran10301141Negan Nutraceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Negan Nutraceuticals Private Limited
Premium access

Shareholding and investment profile for Vidhyalakshmi Venkataramanan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vidhyalakshmi Venkataramanan

Vidhyalakshmi Venkataramanan currently holds 1 directorship: Negan Nutraceuticals Private Limited (Director, since 31 Aug 2023).

Vidhyalakshmi Venkataramanan was first appointed on 31 Aug 2023 as Director at Negan Nutraceuticals Private Limited.

The current boards of Vidhyalakshmi Venkataramanan's companies include Kumaresan Baburajendran (Negan Nutraceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available